ImmunityBio, Inc.: Neoplasms trials
The registry lists 15 Neoplasms studies with ImmunityBio, Inc. as lead sponsor. 0 are open to participants now and 6 have results posted.
Phase 1 13Phase 2 5Phase 3 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- QUILT-3.028: Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid TumorsCompletedNCT03027128Phase 1Results posted
- QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With RituximabTerminatedNCT02384954Phase 1/2Results posted
- A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid TumorsCompletedNCT01946789Phase 1Results posted
- QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the PancreasCompletedNCT01231347Phase 3Results posted
- QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic MelanomaTerminatedNCT01029873Phase 1/2Results posted
- Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic MalignanciesCompletedNCT00496860Phase 1Results posted
- QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.WithdrawnNCT03647423Phase 1/2
- Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid TumorsCompletedNCT02235688Phase 1
- A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder CancerActive, not recruitingNCT02138734Phase 1/2
- Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid TumorsCompletedNCT01706835Phase 1
- Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL in Subjects With Advanced Solid TumorsCompletedNCT01673438Phase 1
- Safety and Maximum Tolerated Dose (MTD) Study of INNO-206 in Subjects With Advanced Solid TumorsCompletedNCT01337505Phase 1
- A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsCompletedNCT01325558Phase 1
- QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid TumorsCompletedNCT00974896Phase 1
- QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell TumorsCompletedNCT00563680Phase 2